This clinical trial tests the impact of providing self-collected human papillomavirus (HPV) testing through the emergency department to increase cervical cancer screening rates among eligible women. Most cases of cervical cancer (CC) occur in never-screened and under-screened people. Disparities in CC screening are more common among a variety of populations, including minorities, patients with lower education levels, the under-insured, and rural individuals. The group most likely to be under-screened is people who use the emergency department as their usual source of care. HPV testing presents the possibility of self sampling for test specimens - providing convenience, privacy, and comfort. Providing self-collected HPV testing through the emergency department may be an effective way to increase cervical cancer screening rates among eligible women.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07345897.
Locations matching your search criteria
United States
New York
Rochester
University of RochesterStatus: Active
Contact: Beau W. Abar
Phone: 585-275-8143
PRIMARY OBJECTIVES:
I. Compare uptake of CC screening through in-emergency department (ED) high risk human papillomavirus (hrHPV) self-sampling to CC screening uptake among historical controls.
II. Evaluate the impact of in-ED HPV self-sampling on the completion of subsequent clinic-based CC testing.
III. Examine operational feasibility of the intervention.
OUTLINE:
Patients who are eligible for screening receive instructions on how to complete the screening and then complete the hrHPV sample self-collection privately in the ED. Patients who decline self screening receive referral for clinic-based screening. Patients who complete sample self-collection receive notification of their results via MyChart and/or a letter.
Patients who complete screening are followed up at 150 days.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationUniversity of Rochester
Principal InvestigatorBeau W. Abar
